8PD * Phase I JAVELIN solid tumor trial of avelumab (MSB0010718C), an anti-PD-L1 antibody: Safety and pharmacokinetics
Arkenau, H.- T., Kelly, K., Patel, M. R., Neuteboom, B., Speit, I., Chin, K., Heery, C. R., Gulley, J. L.Volume:
26
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdv513.08
Date:
November, 2015
File:
PDF, 38 KB
english, 2015